Business Description
Arno Therapeutics Inc
NAICS : 325414
SIC : 2836
ISIN : US0425642032
Description
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage products under the following names: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate, and breast cancer indications; AR-42 is provided for hematological malignancies and solid tumor indications; and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 0.01 | |||||
3-1 Month Momentum % | -50 | |||||
6-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ARNI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arno Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.43 | ||
| Beta | -139.9992 | ||
| 3-Year Sharpe Ratio | 0.45 | ||
| 3-Year Sortino Ratio | 2.05 | ||
| Volatility % | 115.8 | ||
| 14-Day RSI | 0.01 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0002 | ||
| Shares Outstanding (Mil) | 49.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arno Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arno Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.125:1 Stock Split | 2013-10-30 | 3.20 (+0.00%) | ||
| 0.333333:1 Stock Split | 2008-05-09 | -- |
Show
Entries
Arno Therapeutics Inc Frequently Asked Questions
What is Arno Therapeutics Inc(ARNI)'s stock price today?
The current price of ARNI is $0.00. The 52 week high of ARNI is $0.00 and 52 week low is $0.00.
When is next earnings date of Arno Therapeutics Inc(ARNI)?
The next earnings date of Arno Therapeutics Inc(ARNI) is .
Does Arno Therapeutics Inc(ARNI) pay dividends? If so, how much?
Arno Therapeutics Inc(ARNI) does not pay dividend.
Guru Commentaries on OTCPK:ARNI
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Arno Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers